KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (Diluted Average) (2019 - 2026)

Hims & Hers Health's Shares Outstanding (Diluted Average) history spans 8 years, with the latest figure at $228.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 7.4% to $228.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $228.4 million, a 7.4% decrease, with the full-year FY2025 number at $258.2 million, up 9.05% from a year prior.
  • Shares Outstanding (Diluted Average) hit $228.4 million in Q1 2026 for Hims & Hers Health, down from $258.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for HIMS hit a ceiling of $258.2 million in Q4 2025 and a floor of $202.7 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $225.1 million across 5 years, with a median of $228.4 million in 2026.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 32.41% in 2022 and later dropped 7.4% in 2026.
  • Tracing HIMS's Shares Outstanding (Diluted Average) over 5 years: stood at $204.5 million in 2022, then increased by 2.36% to $209.3 million in 2023, then increased by 13.12% to $236.8 million in 2024, then increased by 9.05% to $258.2 million in 2025, then fell by 11.57% to $228.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HIMS at $228.4 million in Q1 2026, $258.2 million in Q4 2025, and $255.6 million in Q3 2025.